Dr. Igal Staw, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 Post Rd, Ste 202, Fairfield, CT 06824 Phone: 203-853-1919 Fax: 203-855-9002 |
Eric I Gentry, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Kings Hwy E, Suite 204, Fairfield, CT 06825 Phone: 203-610-6300 Fax: 203-610-6347 |
Dr. Stasia J Wieber, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Kings Hwy E, Suite 204, Fairfield, CT 06825 Phone: 203-610-6300 Fax: 203-610-6347 |
Dr. A. Joel Papowitz, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 179 Pine Creek Ave, Fairfield, CT 06824 Phone: 203-292-9800 |
Philip E Greenspan, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Kings Hwy E, Suite 204, Fairfield, CT 06825 Phone: 203-610-6300 Fax: 203-610-6347 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier through LRP targeting, announced today that preclinical data on two of its oncology programs, ANG1005 and ANG1007, for the treatment of brain cancers, as well as data demonstrating the utility of Angiochem's EPiC platform to achieve efficient penetration rates in the brain and in cancer tumor tissue, will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010.
Thursday's state news includes concerns over Medicaid reimbursement cuts in Colorado, the opening of the Utah Health Exchange amidst skyrocketing premiums and the high number of uninsured in Texas.
The method's high sensitivity lies in the customized environment for the substance of interest. Dresden's Adrian Keller and his colleagues have constructed a type of "golden trap" capable of capturing the molecules and thereby enabling their detection.
› Verified 1 days ago